RG
Redmile Group’s Pliant Therapeutics PLRX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.89M | Sell |
1,632,577
-420,982
| -21% | -$488K | 0.2% | 43 |
|
2025
Q1 | $2.77M | Sell |
2,053,559
-841,919
| -29% | -$1.14M | 0.26% | 45 |
|
2024
Q4 | $38.1M | Sell |
2,895,478
-302,013
| -9% | -$3.98M | 2.66% | 11 |
|
2024
Q3 | $35.8M | Sell |
3,197,491
-12,100
| -0.4% | -$136K | 2.11% | 23 |
|
2024
Q2 | $34.5M | Buy |
3,209,591
+112,371
| +4% | +$1.21M | 2.09% | 20 |
|
2024
Q1 | $46.1M | Buy |
3,097,220
+400,572
| +15% | +$5.97M | 1.69% | 22 |
|
2023
Q4 | $48.8M | Buy |
2,696,648
+18,549
| +0.7% | +$336K | 1.75% | 16 |
|
2023
Q3 | $46.4M | Hold |
2,678,099
| – | – | 2.21% | 9 |
|
2023
Q2 | $48.5M | Sell |
2,678,099
-247,549
| -8% | -$4.49M | 1.86% | 13 |
|
2023
Q1 | $77.8M | Sell |
2,925,648
-952,951
| -25% | -$25.3M | 3.38% | 6 |
|
2022
Q4 | $75M | Sell |
3,878,599
-629,605
| -14% | -$12.2M | 3.07% | 9 |
|
2022
Q3 | $94.2M | Buy |
4,508,204
+1,439,203
| +47% | +$30.1M | 3.65% | 5 |
|
2022
Q2 | $24.6M | Sell |
3,069,001
-11,800
| -0.4% | -$94.5K | 0.94% | 31 |
|
2022
Q1 | $21.6M | Sell |
3,080,801
-2,700
| -0.1% | -$18.9K | 0.67% | 40 |
|
2021
Q4 | $41.6M | Hold |
3,083,501
| – | – | 0.95% | 32 |
|
2021
Q3 | $52M | Sell |
3,083,501
-72,900
| -2% | -$1.23M | 0.91% | 35 |
|
2021
Q2 | $91.9M | Sell |
3,156,401
-50,792
| -2% | -$1.48M | 1.36% | 25 |
|
2021
Q1 | $126M | Sell |
3,207,193
-181,183
| -5% | -$7.13M | 1.78% | 16 |
|
2020
Q4 | $77M | Sell |
3,388,376
-3,381
| -0.1% | -$76.8K | 0.93% | 37 |
|
2020
Q3 | $76.8M | Sell |
3,391,757
-18,900
| -0.6% | -$428K | 1.41% | 23 |
|
2020
Q2 | $111M | Buy |
+3,410,657
| New | +$111M | 2.04% | 13 |
|